Human CC chemokine I-309, structural consequences of the additional disulfide bond

被引:28
作者
Keizer, DW
Crump, MP
Lee, TW
Slupsky, CM
Clark-Lewis, I
Sykes, BD [1 ]
机构
[1] Univ Alberta, Prot Engn Network Ctr Excellence, Heritage Med Res Ctr 713, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Dept Biochem, Heritage Med Res Ctr 713, Edmonton, AB T6G 2S2, Canada
[3] Univ Southampton, Dept Biochem, Southampton SO16 7PX, Hants, England
[4] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada
[5] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada
关键词
D O I
10.1021/bi000089l
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
I-309 is a member of the CC subclass of chemokines and is one of only three human chemokines known to contain an additional, third disulfide bond. The three-dimensional solution structure of I-309 was determined by H-1 nuclear magnetic resonance spectroscopy and dynamic simulated annealing. The structure of I-309, which remains monomeric at high concentrations, was determined on the basis of 978 experimental restraints. The N-terminal region of I-309 was disordered, as has been previously observed for the CC chemokine eotaxin but not others such as MCP-1 and RANTES. This was followed in I-309 by a well-ordered region between residues 13 and 69 that consisted of a 3(10)-helix, a triple-stranded antiparallel beta-sheet, and finally a C-terminal alpha-helix. Root-mean-square deviations of 0.61 and 1.16 were observed for the backbone and heavy atoms, respectively. A comparison of I-309 to eotaxin and HCC-2 revealed a significant structural change in the C-terminal region of the protein. The alpha-helix normally present in chemokines was terminated early and was followed by a short section of extended strand. These changes were a direct result of the additional disulfide bond present in this protein. An examination of the I-309 structure will aid in an understanding of the specificity of this protein with its receptor, CCR8.
引用
收藏
页码:6053 / 6059
页数:7
相关论文
共 66 条
  • [1] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
  • [2] Baggiolini M, 1995, Clin Exp Immunol, V101 Suppl 1, P5
  • [3] Human chemokines: An update
    Baggiolini, M
    Dewald, B
    Moser, B
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 675 - 705
  • [4] Bernardini G, 1998, EUR J IMMUNOL, V28, P582, DOI 10.1002/(SICI)1521-4141(199802)28:02<582::AID-IMMU582>3.0.CO
  • [5] 2-A
  • [6] BRUNGER AT, 1993, XPLOR VERSION 3 1 SY
  • [7] The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
    Choe, H
    Farzan, M
    Sun, Y
    Sullivan, N
    Rollins, B
    Ponath, PD
    Wu, LJ
    Mackay, CR
    LaRosa, G
    Newman, W
    Gerard, N
    Gerard, C
    Sodroski, J
    [J]. CELL, 1996, 85 (07) : 1135 - 1148
  • [8] THE 3-DIMENSIONAL SOLUTION STRUCTURE OF RANTES
    CHUNG, CW
    COOKE, RM
    PROUDFOOT, AEI
    WELLS, TNC
    [J]. BIOCHEMISTRY, 1995, 34 (29) : 9307 - 9314
  • [9] CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075
  • [10] STRUCTURE-ACTIVITY-RELATIONSHIPS OF CHEMOKINES
    CLARKLEWIS, I
    KIM, KS
    RAJARATHNAM, K
    GONG, JH
    DEWALD, B
    MOSER, B
    BAGGIOLINI, M
    SYKES, BD
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (05) : 703 - 711